China Regenerative Medicine International (China)
- Research works
- 16 ▼ 68% vs 2013–17
- Citations
- 251 15.3 per fractional work
- Top-10% rate
- 15.6% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: China Regenerative Medicine International (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 8.1×. Every wedge is a field page.
Which research topics does China Regenerative Medicine International (China) publish most on?
By volume in 2022–2025: COVID-19 and Mental Health, MicroRNA in disease regulation, Participatory Visual Research Methods and Circular RNAs in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 COVID-19 and Mental Health Clinical Psychology 0 works
- 2 MicroRNA in disease regulation Cancer Research 0 works
- 3 Participatory Visual Research Methods Sociology and Political Science 0 works
- 4 Circular RNAs in diseases Molecular Biology 0 works
- 5 Epigenetics and DNA Methylation Molecular Biology 0 works
- 6 Geographic Information Systems Studies Geography, Planning and Development 0 works
- 7 Disaster Management and Resilience Sociology and Political Science 0 works
- 8 Telomeres, Telomerase, and Senescence Physiology 0 works
- 9 Lipoproteins and Cardiovascular Health Surgery 0 works
- 10 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has China Regenerative Medicine International (China)'s research output changed?
Output in 2018–2022 was 68% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wanchai
- Esquel Group (China)
- Beijing Enterprises Water Group (China)
- Hong Kong Tuberculosis, Chest and Heart Diseases Association
- Champion Technology Holdings (China)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.